The world's leading automated proofreading software

The Critical Impact of Labeling Errors in the Pharmaceutical Industry

Published By: Vineed Ravindranath

2 minutes read
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Table of Contents

In the complex landscape of pharmaceutical manufacturing, every detail matters. From the formulation of the drug to its packaging and labeling, precision is vital. However, despite stringent regulations and quality control measures, labeling errors persist, posing significant risks to patient safety and public health.

A recent analysis of FDA recalls spanning the years 2012 to 2023 sheds light on the prevalence and consequences of labeling-related drug recalls. Among the myriad reasons for recalls—contamination, manufacturing issues, out-of-specification (OOS) results, and sterility—labeling errors emerge as a concerning trend. The data reveals that approximately 8% of all FDA recalls during this period were attributed to labeling issues, emphasizing the magnitude of this problem.

Labeling errors can have dire consequences

The consequences of such errors can be dire. Patients rely heavily on the information provided on drug labels to ensure safe and effective use. However, when labels are mixed up, patients may receive the wrong medication or incorrect dosage, leading to serious health complications.

 For example, a recall by Endo Pharmaceuticals was initiated due to labeling inaccuracies regarding the dosage regimen of Robaxin 750 mg tablets. Such discrepancies can result in patients inadvertently taking incorrect doses, jeopardizing their well-being.

Furthermore, labeling errors undermine the integrity of the entire healthcare system. Patients place their trust in pharmaceutical products and the information provided on their labels. Any deviation from the prescribed instructions can erode this trust and compromise patient safety. Moreover, the repercussions may extend beyond individual patients to healthcare providers, regulatory authorities, and pharmaceutical manufacturers.

Labeling Compliance

To mitigate the risks associated with labeling errors, regulatory bodies worldwide have implemented stringent guidelines and standards for labeling compliance. These regulations encompass every aspect of labeling, from content accuracy to format and presentation. Additionally, pharmaceutical companies are urged to implement robust quality control measures throughout the manufacturing and labeling processes to minimize the likelihood of errors.

Reduce the risk

So how can pharmaceutical companies mitigate the risk of labeling errors? Using a content comparison tool, like TVT is an easy and reliable option. Content comparison (or proofreading) software allows users to compare digital files with different layouts and in different formats (ex: Word to PDF) to catch any potential deviations early in the process – before the information is placed in the hands of patients.

The software will instantly “proofread” and identify any deviations between the two digital files (ex: font size, graphics, font style, barcodes, spelling, etc.) You just need to determine whether these deviations are acceptable or not. An audit trail report is then generated to ensure quality compliance.

In conclusion, labeling errors in the pharmaceutical industry represent a critical challenge with far-reaching implications. While efforts to address this issue have been made through regulatory interventions and quality control measures, implementing technology tools to remove the risk of human error is one solution that can be implemented in any workflow today. By prioritizing accuracy and adherence to labeling regulations, stakeholders can uphold patient safety and maintain the trust and integrity of the healthcare system.

Pharma_Email_Subscription

Sign up for our exclusive 6-email series designed to enhance your regulatory skill set.

Do you want to find out more about how your proofreading life can be easier? Get in touch and we’ll tell you all about it.

Share this article

Vineed Ravindranath profile picture

Vineed Ravindranath

Account Executive, Schlafender Hase

Vineed is an IT sales professional with over a decade of software solutions experience.

Learn More

Subscribe to our blog

In the complex landscape of pharmaceutical manufacturing, every detail matters. From the formulation of the drug to its packaging and labeling, precision is vital. However, despite stringent regulations and quality control measures, labeling errors persist, posing significant risks to patient safety and public health.

A recent analysis of FDA recalls spanning the years 2012 to 2023 sheds light on the prevalence and consequences of labeling-related drug recalls. Among the myriad reasons for recalls—contamination, manufacturing issues, out-of-specification (OOS) results, and sterility—labeling errors emerge as a concerning trend. The data reveals that approximately 8% of all FDA recalls during this period were attributed to labeling issues, emphasizing the magnitude of this problem.

Labeling errors can have dire consequences

The consequences of such errors can be dire. Patients rely heavily on the information provided on drug labels to ensure safe and effective use. However, when labels are mixed up, patients may receive the wrong medication or incorrect dosage, leading to serious health complications.

 For example, a recall by Endo Pharmaceuticals was initiated due to labeling inaccuracies regarding the dosage regimen of Robaxin 750 mg tablets. Such discrepancies can result in patients inadvertently taking incorrect doses, jeopardizing their well-being.

Furthermore, labeling errors undermine the integrity of the entire healthcare system. Patients place their trust in pharmaceutical products and the information provided on their labels. Any deviation from the prescribed instructions can erode this trust and compromise patient safety. Moreover, the repercussions may extend beyond individual patients to healthcare providers, regulatory authorities, and pharmaceutical manufacturers.

Labeling Compliance

To mitigate the risks associated with labeling errors, regulatory bodies worldwide have implemented stringent guidelines and standards for labeling compliance. These regulations encompass every aspect of labeling, from content accuracy to format and presentation. Additionally, pharmaceutical companies are urged to implement robust quality control measures throughout the manufacturing and labeling processes to minimize the likelihood of errors.

Reduce the risk

So how can pharmaceutical companies mitigate the risk of labeling errors? Using a content comparison tool, like TVT is an easy and reliable option. Content comparison (or proofreading) software allows users to compare digital files with different layouts and in different formats (ex: Word to PDF) to catch any potential deviations early in the process – before the information is placed in the hands of patients.

The software will instantly “proofread” and identify any deviations between the two digital files (ex: font size, graphics, font style, barcodes, spelling, etc.) You just need to determine whether these deviations are acceptable or not. An audit trail report is then generated to ensure quality compliance.

In conclusion, labeling errors in the pharmaceutical industry represent a critical challenge with far-reaching implications. While efforts to address this issue have been made through regulatory interventions and quality control measures, implementing technology tools to remove the risk of human error is one solution that can be implemented in any workflow today. By prioritizing accuracy and adherence to labeling regulations, stakeholders can uphold patient safety and maintain the trust and integrity of the healthcare system.

Pharma_Email_Subscription

Sign up for our exclusive 6-email series designed to enhance your regulatory skill set.

Do you want to find out more about how your proofreading life can be easier? Get in touch and we’ll tell you all about it.

Subscribe to our blog

Related Blogs

Esko Precision Talks Webinar

May 22, 2025

Schlafender Hase Team

Precision Talks: Optimizing Packaging Workflows with Compliance and Innovation

Join Chris Janczar from Esko and Marc Chaillou from Schlafender Hase for an exclusive discussion on how automation and digital maturity can transform your packaging workflows. This session is designed for professionals who are responsible for optimizing workflows, approving artworks, and reducing risk in their packaging process.

Esko Precision Talks Webinar
< 1 minute read

Precision Talks: Optimizing Packaging Workflows with Compliance and Innovation

Join Chris Janczar from Esko and Marc Chaillou from Schlafender Hase for an exclusive discussion on how automation and digital maturity can transform your packaging workflows. This session is designed for professionals who are responsible for optimizing workflows, approving artworks, and reducing risk in their packaging process.

xtalks press release

May 20, 2025

Schlafender Hase Team

Reducing Labeling Risks: Applying Pharma’s Compliance Playbook to Food Labeling, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn why food labeling errors continue to happen despite existing processes. Attendees will gain insights into why labeling errors led to nearly half of food recalls in 2024 and what actionable steps can be taken to avoid food recall. The featured speakers will discuss which pharma’s best practices food manufacturers can apply to build stronger labeling standards to minimize compliance risks while increasing speed to market.

xtalks press release
2 minutes read

Reducing Labeling Risks: Applying Pharma’s Compliance Playbook to Food Labeling, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn why food labeling errors continue to happen despite existing processes. Attendees will gain insights into why labeling errors led to nearly half of food recalls in 2024 and what actionable steps can be taken to avoid food recall. The featured speakers will discuss which pharma’s best practices food manufacturers can apply to build stronger labeling standards to minimize compliance risks while increasing speed to market.

Barcode Grading in a Digital World - a Guide for FMCG

May 14, 2025

Schlafender Hase Team

Barcode Grading in a Digital World – A Guide for FMCG/CPG Industries

How to Ensure Barcode Accuracy in a Fast-Moving Market: Barcodes are the backbone of traceability, compliance, and retail readiness. But in today’s digital-first design workflows, traditional print-based grading methods no longer tell the full story.

Barcode Grading in a Digital World - a Guide for FMCG
< 1 minute read

Barcode Grading in a Digital World – A Guide for FMCG/CPG Industries

How to Ensure Barcode Accuracy in a Fast-Moving Market: Barcodes are the backbone of traceability, compliance, and retail readiness. But in today’s digital-first design workflows, traditional print-based grading methods no longer tell the full story.